117 related articles for article (PubMed ID: 9308733)
1. Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: analysis of 427 cases.
Anton RC; Brown RW; Younes M; Gondo MM; Stephenson MA; Cagle PT
Hum Pathol; 1997 Sep; 28(9):1079-82. PubMed ID: 9308733
[TBL] [Abstract][Full Text] [Related]
2. Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma.
Ritter JH; Dresler CM; Wick MR
Hum Pathol; 1995 Nov; 26(11):1227-32. PubMed ID: 7590697
[TBL] [Abstract][Full Text] [Related]
3. High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.
Anagnostou VK; Lowery FJ; Zolota V; Tzelepi V; Gopinath A; Liceaga C; Panagopoulos N; Frangia K; Tanoue L; Boffa D; Gettinger S; Detterbeck F; Homer RJ; Dougenis D; Rimm DL; Syrigos KN
BMC Cancer; 2010 May; 10():186. PubMed ID: 20459695
[TBL] [Abstract][Full Text] [Related]
4. bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Nakamori S; Tateishi R
J Surg Oncol; 1997 Jan; 64(1):48-54. PubMed ID: 9040801
[TBL] [Abstract][Full Text] [Related]
5. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
Anton RC; Coffey DM; Gondo MM; Stephenson MA; Brown RW; Cagle PT
Mod Pathol; 2000 Nov; 13(11):1167-72. PubMed ID: 11106072
[TBL] [Abstract][Full Text] [Related]
6. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers.
Grossi F; Loprevite M; Chiaramondia M; Ceppa P; Pera C; Ratto GB; Serrano J; Ferrara GB; Costa R; Boni L; Ardizzoni A
Eur J Cancer; 2003 Jun; 39(9):1242-50. PubMed ID: 12763212
[TBL] [Abstract][Full Text] [Related]
8. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G
Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614
[TBL] [Abstract][Full Text] [Related]
9. bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time.
Ohsaki Y; Toyoshima E; Fujiuchi S; Matsui H; Hirata S; Miyokawa N; Kubo Y; Kikuchi K
Clin Cancer Res; 1996 May; 2(5):915-20. PubMed ID: 9816250
[TBL] [Abstract][Full Text] [Related]
10. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
Volm M; Koomägi R
Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer.
Ko E; Kim Y; Cho EY; Han J; Shim YM; Park J; Kim DH
Ann Surg Oncol; 2013 Mar; 20(3):1005-12. PubMed ID: 23115005
[TBL] [Abstract][Full Text] [Related]
12. Lung carcinoma with rhabdoid component. A series of seven cases associated with uncommon types of non-small cell lung carcinomas and alveolar entrapment.
Izquierdo-Garcia FM; Moreno-Mata N; Herranz-Aladro ML; Cañizares MA; Alvarez-Fernandez E
Histol Histopathol; 2010 Oct; 25(10):1287-95. PubMed ID: 20712013
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer.
Laudanski J; Niklinska W; Burzykowski T; Chyczewski L; Niklinski J
Eur Respir J; 2001 Apr; 17(4):660-6. PubMed ID: 11401061
[TBL] [Abstract][Full Text] [Related]
14. Relationship of Fas, FasL, p53 and bcl-2 expression in human non-small cell lung carcinomas.
Li Y; Xu KP; Jiang D; Zhao J; Ge JF; Zheng SY
Int J Clin Exp Pathol; 2015; 8(11):13978-86. PubMed ID: 26823709
[TBL] [Abstract][Full Text] [Related]
15. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
Bellotti M; Elsner B; Paez De Lima A; Esteva H; Marchevsky AM
Mod Pathol; 1997 Dec; 10(12):1221-7. PubMed ID: 9436967
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.
Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C
Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics.
Sterlacci W; Tzankov A; Veits L; Oberaigner W; Schmid T; Hilbe W; Fiegl M
Am J Clin Pathol; 2011 Apr; 135(4):611-8. PubMed ID: 21411784
[TBL] [Abstract][Full Text] [Related]
19. Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas.
Volm M; Koomägi R; Mattern J; Stammler G
Br J Cancer; 1997; 75(12):1774-8. PubMed ID: 9192980
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases.
Kren L; Brazdil J; Hermanova M; Goncharuk VN; Kallakury BV; Kaur P; Ross JS
Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):44-9. PubMed ID: 15163019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
